Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2021-12-15 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
关于使用部分暂时闲置募集资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Shenzhen Huitai Medical Equipment Co., Ltd. regarding the use of temporarily idle raised funds for cash management. It details the board meeting approval, investment scope, amount, duration, risk analysis, and independent opinions. The document does not contain financial statements or detailed financial results but is a regulatory disclosure about the company's use of idle raised funds. It is not an annual or interim report, earnings release, or audit report. The document is a formal announcement about capital management activities related to fundraising proceeds, fitting the category of Capital/Financing Update (CAP). The document length is under 5,000 characters, but it contains substantive information about the use of funds, not just a report publication notice or certification, so it is not RPA or RNS. Therefore, the best classification is CAP with high confidence.
2021-12-15 Chinese
独立董事关于第一届董事会第十五次会议相关议案的事前认可意见
Board/Management Information Classification · 95% confidence The document is a statement from independent directors regarding their prior approval opinions on agenda items for the 15th meeting of the first board of directors of Shenzhen Huitai Medical Devices Co., Ltd. It references regulatory guidelines and company bylaws related to independent directors and board meetings. The content is focused on board meeting agenda approval and independent director opinions, not on financial results, audit reports, or shareholder voting results. The document length is short (733 characters) and it is not a report itself but a formal opinion related to board management matters. Therefore, the document fits best under Board/Management Information (MANG).
2021-12-15 Chinese
关于参加2021深圳辖区“沟通传递价值，交流创造良好生态”上市公司投资者网上集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Shenzhen Huitai Medical Equipment Co., Ltd. about participating in an online investor collective reception day event organized by Shenzhen Stock Exchange and related entities. It describes the event details, including date, time, and participation method, and invites investors to join. There is no financial data, no report attached or referenced, no voting results, no management changes, no earnings or audit information. The document is an announcement related to investor relations activities but does not fit into categories like Investor Presentation or Call Transcript because it is about an event participation notice. Given the nature and length (635 characters), it is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2021-11-26 Chinese
2021年第三季度报告
Interim / Quarterly Report Classification · 95% confidence The document is titled "2021 年第三季度报告" which translates to "2021 Third Quarter Report." It contains detailed financial data including income statements, balance sheets, cash flow statements, and notes on financial performance for the third quarter of 2021. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The content includes unaudited quarterly financial statements and management assurances about the accuracy of the report. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements and substantive financial data and analysis. There is no indication that this is an announcement of a report or a certification letter, so it is not classified as RPA or RNS. Therefore, the correct classification is IR with high confidence. 9M 2021
2021-10-28 Chinese
2021年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2021 年半年度报告" which translates to "2021 Semi-Annual Report". It contains detailed financial data, management discussion and analysis, company overview, core technologies, and other comprehensive information typical of an interim or quarterly report. The document length is about 15,000 characters, indicating a full report rather than a brief announcement. It explicitly states the report period as January 1, 2021 to June 30, 2021, confirming it covers a half-year period. The content includes financial statements, management analysis, risk factors, and operational details, which are characteristic of an Interim / Quarterly Report (IR). There is no indication that this is an announcement of a report or a certification letter, so it is not RPA or RNS. Therefore, the correct classification is Interim / Quarterly Report (IR). H1 2021
2021-08-24 Chinese
2021年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2021 半年度报告摘要' which translates to '2021 Half-Year Report Summary'. It contains detailed financial data for the half-year period, including total assets, net profit, earnings per share, and shareholder information. The document explicitly states it is a summary of the half-year report and advises investors to read the full report for comprehensive details. The presence of substantive financial data and analysis for a period shorter than a full fiscal year confirms it is an Interim / Quarterly Report. The document length is 3676 characters, which is sufficient for a summary but not a full annual report. It is not an announcement or a certification but contains actual financial data and management discussion. Therefore, the correct classification is Interim / Quarterly Report (IR). H1 2021
2021-08-24 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.